Pharma
Trump's 100% tariff on pharma unlikely to have adverse impact on domestic industry: Experts
Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr
Bloodbath in pharma stocks amid reports of Trump planning tariffs; Aurobindo Pharma down 11%
Indian pharma players can deliver 100 new drugs by 2047: Zydus Chairman
Senores Pharmaceuticals shares surge nearly 43% in market debut trade